BridgeBio Pharma, Inc. (BBIO)
66.17
-2.14
(-3.13%)
USD |
NASDAQ |
Feb 25, 11:20
BridgeBio Pharma Market Cap : 12.68B for Feb. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Insmed, Inc. | 32.65B |
| Mirum Pharmaceuticals, Inc. | 5.519B |
| Cogent Biosciences, Inc. | 6.358B |
| Alnylam Pharmaceuticals, Inc. | 43.41B |
| Sarepta Therapeutics, Inc. | 1.990B |
Market Cap Related Metrics
| PS Ratio | 35.63 |
| PEG Ratio | -0.2148 |
| Price | 66.17 |
| Earnings Yield | -6.33% |
| PEGY Ratio | -0.2148 |